Status:
COMPLETED
Clinical Effort Against Smoke Exposure in Cystic Fibrosis
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
Cystic Fibrosis Foundation
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The study will test the feasibility, acceptability, and preliminary efficacy of a multi-component smoking cessation intervention tailored to the needs of caregivers of children with CF and delivered i...
Detailed Description
This is a single-center, randomized, open-label study to test the feasibility and acceptability (primary outcomes) and preliminary efficacy (secondary outcome) of a multi-component smoking-cessation i...
Eligibility Criteria
Inclusion
- Adult familial caregiver of a child with CF aged \<18 years
- Speak English
- Report smoking at least 1 cigarette in the previous week
- Not enrolled in a smoking cessation program
Exclusion
- Do not report smoking at least 1 cigarette in the previous week
- Currently enrolled in a smoking cessation program.
Key Trial Info
Start Date :
July 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 27 2022
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04777344
Start Date
July 8 2021
End Date
September 27 2022
Last Update
October 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233